Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CCR7 (CD197) expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, κ Isotype Control (Cat. No. 560548; shaded histogram and middle panel) or FITC Rat Anti-Human CCR7 (CD197) (Cat. No. 560548/561675; unshaded histogram and right panel). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR™ II flow cytometry system.
Flow cytometric analysis of CCR7 (CD197) expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, κ Isotype Control (Cat. No. 560548; shaded histogram and middle panel) or FITC Rat Anti-Human CCR7 (CD197) (Cat. No. 560548/561675; unshaded histogram and right panel). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR™ II flow cytometry system.
Flow cytometric analysis of CCR7 (CD197) expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, κ Isotype Control (Cat. No. 560548; shaded histogram and middle panel) or FITC Rat Anti-Human CCR7 (CD197) (Cat. No. 560548/561675; unshaded histogram and right panel). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR™ II flow cytometry system.
Flow cytometric analysis of CCR7 (CD197) expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, κ Isotype Control (Cat. No. 560548; shaded histogram and middle panel) or FITC Rat Anti-Human CCR7 (CD197) (Cat. No. 560548/561675; unshaded histogram and right panel). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR™ II flow cytometry system.
Flow cytometric analysis of CCR7 (CD197) expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, κ Isotype Control (Cat. No. 560548; shaded histogram and middle panel) or FITC Rat Anti-Human CCR7 (CD197) (Cat. No. 560548/561675; unshaded histogram and right panel). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR™ II flow cytometry system.
Flow cytometric analysis of CCR7 (CD197) expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, κ Isotype Control (Cat. No. 560548; shaded histogram and middle panel) or FITC Rat Anti-Human CCR7 (CD197) (Cat. No. 560548/561675; unshaded histogram and right panel). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR™ II flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Flow cytometry: Chemokine receptors are known to internalize during manipulation resulting in low frequency expression. Immunophenotyping studies of chemokine receptors need to be performed on freshly collected whole blood (<24 Hrs). Incubation with the antibody should be done at 4°C in the dark. Cellular manipulation, such as Ficoll separation, freezing, or exposure to cold temperatures prior to staining have been shown to cause a decrease in staining intensity and/or inconsistent results.
Investigators should note that alternative staining procedures may be neccessary. A multiple-step staining procedure is strongly recommended, in some instances, to amplify immunofluorescent signals for the flow cytometric analysis of human CD197 (CCR7) expression. Investigators may find the Purified Rat Anti-Human CCR7 (CD197) antibody (Cat. No. 552175) to be useful in conjunction with appropriate secondary and tertiary reagents for detecting low frequency expression, such as with Biotin Mouse Anti-Rat IgG2a (Cat. No. 553894) and PE Streptavidin (Cat. No. 554061).
The monoclonal antibody 3D12 reacts with the human CC chemokine receptor, CCR7. CCR7 (previously known as BLR-2, EBI-1 and CMKBR7), a seven-transmembrane, G-protein-coupled receptor, is the specific receptor for CC chemokines, MIP-3β/Exodus 3/ELC/ CCL19 and 6Ckine/Exodus 2/SLC/TCA4/CCL21. It has been shown that CCR7 mRNA is expressed mainly in lymphoid tissues including spleen, lymph nodes and tonsil. CCR7 mRNA was also detected in peripheral T and B lymphocytes, in bone marrow and cord blood CD34-positive cells and mature dendritic cells. The human CCR7 gene, unlike other CC chemokine receptor genes, has been mapped to chromosome 17q12. The immunogen used to generate 3D12 hybridoma was the N-terminus as well as parts of the second extracellular loop of human CCR7 protein. The monoclonal antibody 3D12 recognizes an epitope mapping to the N-terminus of human CCR7.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.